Latest thinking.

Explore our latest insights and perspectives in these life science resources, news articles, and events.

Topic

Content Type

Lessons to optimize EMA regulatory success using sin...

We set out to understand the likelihood of regulatory approval of oncology-based single-arm trials by the European Medical Agency (EMA).

Medicare Price Negotiation: Putnam’s Round One Picks

As provisions of the Inflation Reduction Act (IRA) of 2022 begin to take effect, Putnam continues to analyze the implications…

New Principal out of London Joins Putnam

Putnam is pleased to announce the addition of Stephen McGarry to the team. Steve started with Putnam in June 2023 as a...

Distributional cost‑effectiveness analysis of treatm...

Putnam aimed to conduct an aggregate DCEA of two NSCLC treatments recommended by NICE, and identify key drivers of the analysis.

A new model for driving patient engagement in health...

Supporting and empowering patients are objectives stated by nearly every life science company. Yet efforts to support patient engagement often...

Real-World Evaluation of Treatment Patterns and Reso...

Putnam PHMR’s client needed a detailed description of multiple myeloma treatment patterns and resource utilization in Japanese patients...

Trends in Medical Affairs at MASS East 2023

The dialogue at the Medical Affairs Strategic Summit East conference highlighted the enthusiasm within Medical Affairs to leverage artificial

Global commercialization blueprint for emerging biotech

An emerging biotech sought Putnam’s guidance to design and execute the global commercialization of their asset for a rare oncology indication.

Designing a lean launch strategy and GTM model

A global, top-10 pharma client sought Putnam’s guidance on developing a lean launch strategy for a novel cell therapy in oncology.

Re-envisioning stakeholder engagement through the “M...

A rapidly shifting healthcare landscape and a wave of cost-containment initiatives destined to put further pressure on the pricing of pharmaceuticals

Dynamic disease modeling in NSCLC

The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.

Webinar on the IRA in partnership with BioCentury

Scott Briggs, Principal, joined a live panel of industry experts to discuss the Inflation Reduction Act on March 30th.

Load 12 more of 68

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Get in touch

Centers of Excellence